Raymond James Reiterates “C$13.50” Price Target for Vitalhub (TSE:VHI)

Raymond James set a C$13.50 price objective on Vitalhub (TSE:VHI) in a research note published on Thursday morning,BayStreet.CA reports. The firm currently has an outperform rating on the stock.

Several other research analysts have also recently issued reports on VHI. Canaccord Genuity Group raised their price objective on Vitalhub from C$12.00 to C$12.50 and gave the stock a “buy” rating in a research note on Thursday, January 16th. Scotiabank set a C$14.00 price target on shares of Vitalhub and gave the stock an “outperform” rating in a research report on Thursday, January 30th. Four investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, Vitalhub has a consensus rating of “Buy” and a consensus price target of C$11.92.

Vitalhub Price Performance

TSE VHI opened at C$10.24 on Thursday. The stock’s fifty day moving average price is C$10.48 and its 200 day moving average price is C$10.34. Vitalhub has a 1 year low of C$5.80 and a 1 year high of C$12.09. The company has a market cap of C$553.91 million, a price-to-earnings ratio of 166.55, a PEG ratio of 1.18 and a beta of 1.26.

About Vitalhub

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.